Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
The Journal of Allergy and Clinical Immunology
|
January 15, 2019
Reply
Necdet B Gunsoy, Daniel J Bratton, Frank C Albers, et al.
BMC Pulmonary Medicine
|
April 29, 2017
The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA
Robert Y Suruki, Jonas B Daugherty, Nada Boudiaf, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2017
Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies
Frank C Albers, Robert G Price, Steven G Smith, et al.
BMJ Open Respiratory Research
|
December 10, 2021
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study
Bradley E Chipps, Frank C Albers, Laurence Reilly, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 23, 2019
Clinical burden of illness among patients with severe eosinophilic COPD
Hana Müllerová, Wilhelmine H Meeraus, Dmitry V Galkin, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
December 25, 2019
Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study
Hana Müllerová, Sarah M Cockle, Necdet B Gunsoy, et al.
Journal of Asthma and Allergy
|
August 28, 2024
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design
Craig LaForce, Frank C Albers, Mark Cooper, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 6, 2018
Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma
Hector Ortega, Steven W Yancey, Oliver N Keene, et al.
Respiratory Research
|
August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
Frank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology
|
December 10, 2017
Biomarkers for severe eosinophilic asthma
Steven W Yancey, Oliver N Keene, Frank C Albers, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
The Journal of Allergy and Clinical Immunology
|
January 15, 2019
Reply
Necdet B Gunsoy, Daniel J Bratton, Frank C Albers, et al.
BMC Pulmonary Medicine
|
April 29, 2017
The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA
Robert Y Suruki, Jonas B Daugherty, Nada Boudiaf, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2017
Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies
Frank C Albers, Robert G Price, Steven G Smith, et al.
BMJ Open Respiratory Research
|
December 10, 2021
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study
Bradley E Chipps, Frank C Albers, Laurence Reilly, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 23, 2019
Clinical burden of illness among patients with severe eosinophilic COPD
Hana Müllerová, Wilhelmine H Meeraus, Dmitry V Galkin, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
December 25, 2019
Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study
Hana Müllerová, Sarah M Cockle, Necdet B Gunsoy, et al.
Journal of Asthma and Allergy
|
August 28, 2024
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol-Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design
Craig LaForce, Frank C Albers, Mark Cooper, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 6, 2018
Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma
Hector Ortega, Steven W Yancey, Oliver N Keene, et al.
Respiratory Research
|
August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
Frank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology
|
December 10, 2017
Biomarkers for severe eosinophilic asthma
Steven W Yancey, Oliver N Keene, Frank C Albers, et al.
Page
of 5